Synaptic Tau Seeding Precedes Tau Pathology in Human Alzheimer's Disease Brain

Synaptic Tau Seeding Precedes Tau Pathology in Human Alzheimer's Disease Brain

Alzheimer's disease (AD) is defined by the presence of intraneuronal neurofibrillary tangles (NFTs) composed of hyperphosphorylated tau aggregates as well as extracellular amyloid-beta plaques. The presence and spread of tau pathology through the brain is classified by Braak stages and thought...

Full description

Bibliographic Details
Main Authors:	Sarah L. DeVos, Bianca T. Corjuc, Derek H. Oakley, Chloe K. Nobuhara, Riley N. Bannon, Alison Chase, Caitlin Commins, Jose A. Gonzalez, Patrick M. Dooley, Matthew P. Frosch, Bradley T. Hyman
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2018-04-01
Series:	Frontiers in Neuroscience
Subjects:	tau seeding propagation synapses aggregation Alzheimer's disease
Online Access:	http://journal.frontiersin.org/article/10.3389/fnins.2018.00267/full

Similar Items

Synaptic tau: A pathological or physiological phenomenon?
by: Miranda Robbins, et al.
Published: (2021-09-01)

Dendritic/Post-synaptic Tau and Early Pathology of Alzheimer’s Disease
by: Xiaomin Yin, et al.
Published: (2021-06-01)

Tau Oligomers Neurotoxicity
by: Grazyna Niewiadomska, et al.
Published: (2021-01-01)

Synaptic and metabolic gene expression alterations in neurons that are recipients of proteopathic tau seeds
by: Marta Perez-Rando, et al.
Published: (2020-10-01)

Enhanced Tau Protein Translation by Hyper-Excitation
by: Shunsuke Kobayashi, et al.
Published: (2019-11-01)

Cerebrovascular Senescence Is Associated With Tau Pathology in Alzheimer's Disease
by: Annie G. Bryant, et al.
Published: (2020-09-01)

Different tau species lead to heterogeneous tau pathology propagation and misfolding
by: Simon Dujardin, et al.
Published: (2018-11-01)

Contribution of Tau Pathology to Mitochondrial Impairment in Neurodegeneration
by: María J. Pérez, et al.
Published: (2018-07-01)

Non-Canonical Roles of Tau and Their Contribution to Synaptic Dysfunction
by: Giacomo Siano, et al.
Published: (2021-09-01)

Characterization of TauC3 antibody and demonstration of its potential to block tau propagation.
by: Samantha B Nicholls, et al.
Published: (2017-01-01)

Tau and spectraplakins promote synapse formation and maintenance through Jun kinase and neuronal trafficking
by: Andre Voelzmann, et al.
Published: (2016-08-01)

Evolving prion-like tau conformers differentially alter postsynaptic proteins in neurons inoculated with distinct isolates of Alzheimer’s disease tau
by: Lenka Hromadkova, et al.
Published: (2023-09-01)

Differential regional distribution of phosphorylated tau and synapse loss in the nucleus accumbens in tauopathy model mice
by: Taiki Kambe, et al.
Published: (2011-06-01)

Tau Filament Self-Assembly and Structure: Tau as a Therapeutic Target
by: Sebastian S. Oakley, et al.
Published: (2020-11-01)

Regulation of Tau Protein on the Antidepressant Effects of Ketamine in the Chronic Unpredictable Mild Stress Model
by: Gehua Wen, et al.
Published: (2019-04-01)

Plasma tau complements CSF tau and P‐tau in the diagnosis of Alzheimer's disease
by: Silvia Fossati, et al.
Published: (2019-12-01)

Tau-mediated synaptic damage in Alzheimer’s disease
by: Jadhav Santosh, et al.
Published: (2015-01-01)

Soluble P‐tau217 reflects amyloid and tau pathology and mediates the association of amyloid with tau
by: Niklas Mattsson‐Carlgren, et al.
Published: (2021-06-01)

Toxic tau: structural origins of tau aggregation in Alzheimer's disease
by: Abdullah Al Mamun, et al.
Published: (2020-01-01)

Tau oligomers
by: Naruhiko eSahara, et al.
Published: (2014-01-01)

Plasma N-terminal containing tau fragments (NTA-tau): a biomarker of tau deposition in Alzheimer’s Disease
by: Juan Lantero-Rodriguez, et al.
Published: (2024-02-01)

The Fate of Tau Aggregates Between Clearance and Transmission
by: Assel Seitkazina, et al.
Published: (2022-07-01)

Rutin prevents tau pathology and neuroinflammation in a mouse model of Alzheimer’s disease
by: Xiao-ying Sun, et al.
Published: (2021-06-01)

Baicalein inhibits heparin-induced Tau aggregation by initializing non-toxic Tau oligomer formation
by: Shweta Kishor Sonawane, et al.
Published: (2021-02-01)

Selenoprotein P Regulates Synaptic Zinc and Reduces Tau Phosphorylation
by: Arlene C. P. Kiyohara, et al.
Published: (2021-07-01)

Clinical performance and head-to-head comparison of CSF p-tau235 with p-tau181, p-tau217 and p-tau231 in two memory clinic cohorts
by: Juan Lantero-Rodriguez, et al.
Published: (2023-03-01)

CSF and serum total-tau and phospho-tau(181P) in MS patients
by: Jaworski Jacek, et al.
Published: (2011-04-01)

Pharmacogenetic neuronal stimulation increases human tau pathology and trans-synaptic spread of tau to distal brain regions in mice
by: M.K. Schultz, Jr., et al.
Published: (2018-10-01)

Therapies for Tau-associated neurodegenerative disorders: targeting molecules, synapses, and cells
by: Miranda Robbins
Published: (2023-01-01)

Human Tau Isoforms and Proteolysis for Production of Toxic Tau Fragments in Neurodegeneration
by: Ben Boyarko, et al.
Published: (2021-10-01)

In vivo tau pathology is associated with synaptic loss and altered synaptic function
by: Emma M. Coomans, et al.
Published: (2021-02-01)

Tau-Cofactor Complexes as Building Blocks of Tau Fibrils
by: Yann Fichou, et al.
Published: (2019-12-01)

Interaction of Tau with Fe65 links tau to APP
by: Christian Barbato, et al.
Published: (2005-03-01)

Editorial: Tau Protein: Mechanisms From Health to Degeneration
by: Isabel Lastres-Becker, et al.
Published: (2021-11-01)

Secretion of full-length Tau or Tau fragments in cell culture models. Propagation of Tau in vivo and in vitro
by: Pérez Mar, et al.
Published: (2018-03-01)

The role of pathological tau in synaptic dysfunction in Alzheimer’s diseases
by: Moxin Wu, et al.
Published: (2021-11-01)

Antisense Oligonucleotide-Mediated Reduction of HDAC6 Does Not Reduce Tau Pathology in P301S Tau Transgenic Mice
by: Antonio Valencia, et al.
Published: (2021-06-01)

Specific detection of tau seeding activity in Alzheimer’s disease using rationally designed biosensor cells
by: Aurelien Lathuiliere, et al.
Published: (2023-08-01)

Tau Acts in Concert With Kinase/Phosphatase Underlying Synaptic Dysfunction
by: Xing Fan, et al.
Published: (2022-05-01)

Tau Isoform-Driven CBD Pathology Transmission in Oligodendrocytes in Humanized Tau Mice
by: Justyna Zareba-Paslawska, et al.
Published: (2021-01-01)